Compare stocks

TAO Synergies Inc is mainly focused on developing a product platform based on its drug candidate, Bryostatin-1, for the treatment of Alzheimer's disease. The company is also evaluating Bryostatin-1 for other neurodegenerative and cognitive conditions, including Fragile X syndrome and Multiple Sclerosis, which have progressed through pre-clinical testing.

Microsoft sells productivity, security, business, and developer software alongside Azure cloud infrastructure and platform services. Commercial customers pay through subscriptions, software licenses, and usage charges. Consumer businesses include Windows, Xbox, and advertising. Beginning in fiscal 2027, Microsoft reports two segments: agents and infra, containing its commercial software and cloud businesses, and devices and consumer.